CIK: 1307935 - Address: C/O Horizon Therapeutics Plc,, 70 St. Stephen?S Green, Dublin, L2 D02 E2X4
31 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret21120139588612952
P%wins75757575502563
S%ret11144-30-21-32-45-20
S%wins0010010010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/2/23 19:32
9/29/23
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d1,10713.6108186176D
5/2/23 19:32
4/28/23
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.0004495D
6/3/22 16:31
6/2/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDM.d624.150153163D
6/3/22 16:31
6/2/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDS.d-649.900-6-963D
5/2/22 18:15
4/29/22
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.0004591I
4/30/21 19:01
4/30/21
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.000111587I
2/18/21 20:43
2/16/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDM.d1077.110154350D
2/18/21 20:43
2/16/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDS.d-10818.540-6-1150D
6/2/20 16:13
5/29/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDM.d1117.380157435D
6/2/20 16:13
5/29/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasFLDS.d-11111.500-10-2235D
5/4/20 17:33
5/2/20
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.000152576I
5/6/19 17:51
5/3/19
HZNPHorizon Therapeutics Public Ltd CoL2HealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.000153460I
5/7/18 17:02
5/3/18
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.000144049I
5/4/18 16:06
5/3/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasILDM.d754.9801530020D
5/4/17 18:04
5/3/17
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.0033146635I-49-1-10-840-1-22-37
5/10/16 16:39
5/6/16
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsWatkins ThomasL2DM.d00.003353321I16-45-12-5-46-14-5125412
8/21/15 18:32
8/19/15
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsWatkins ThomasL2DP31331.32331016716I99920160-3-17-20-9-7-660-34-35-21
1/26/15 09:00
8/14/14
HZNPHorizon Pharma PlcDEHealthDrugPharmaceutical PreparationsWatkins ThomasILDP599.76276New6D587911437272714511149612914
3/17/14 16:49
3/14/14
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasILDM.d3299.4016350D27036453893321151644-30-21-32-45
3/17/14 16:49
3/14/14
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsWatkins ThomasILDS.d-61817.6616-35-1000D27036453893321151644-30-21-32-45
8/17/12 10:29
6/30/11
HGSIHuman Genome Sciences IncDEHealthBioPrdBiological Products, (No DiagWatkins ThomasMDDOCEOP.am429.67040D
1/7/11 11:50
1/5/11
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP1,45024.16336035232I999-20-2-14040328211-1-69
7/13/10 14:34
7/12/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP1619.643310172D317854-22-27-3-9735-111215-1
7/2/09 13:09
6/30/09
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP21.801811171D-68-445324446-8133-1-13390545961668
11/14/08 13:50
11/12/08
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP2022.025100142170D-82-78-64-73-59-31-34-15-9-31-2313-10999
7/2/08 16:33
7/1/08
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP104.49102370D-50-43-50-16-11-4-8-33142822-64-44
3/12/08 14:30
3/11/08
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP994.9419204268D-62-53-46-54-16-24-16-613311335-90
7/12/07 09:26
7/11/07
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP157.59262448D-32-11-28-18-16-90-100-111128-35
11/14/06 16:33
11/10/06
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP7212.053361546I113317272-1-7-343-2-9-17-23
9/7/06 13:24
9/5/06
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP33411.14203030040D-3-18-192995-4371816-2-15
1/6/05 15:50
1/5/05
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWatkins ThomasMDDOCEOP12011.951210New10D30-1413111012-22108-84-23

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact